Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Paulsen

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Practical Radiation Oncology|November 27, 2014
External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiationKlaus Müller, Guido Henke, Inge Compter, et al.
Frontiers in Oncology|December 30, 2021
A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized TrialsMarco Skardelly, Marlene Kaltenstadler, Felix Behling, et al.
Neuro-Oncology Advances|April 29, 2024
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survivalDaniel Feucht, Patrick Haas, Marco Skardelly, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective EvaluationVlatko Potkrajcic, Cihan Gani, Stefan Georg Fischer, et al.
Frontiers in Oncology|March 7, 2022
Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression SurvivalFelix Behling, Julia Rang, Elena Dangel, et al.
Radiation Oncology (London, England)|March 17, 2010
Decreased 3D observer variation with matched CT-MRI, for target delineation in Nasopharynx cancerCoen R N Rasch, Roel J H M Steenbakkers, Isabelle Fitton, et al.
Cancers|April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
The Oncologist|April 1, 2017
Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed GlioblastomaMarco Skardelly, Elena Dangel, Julia Gohde, et al.
Clinical and Translational Radiation Oncology|June 23, 2021
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG surveyEnrica Seravalli, Petra S Kroon, John M Buatti, et al.
Clinical and Translational Radiation Oncology|December 20, 2023
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)Raphael Bodensohn, Daniel F Fleischmann, Sebastian H Maier, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Practical Radiation Oncology|November 27, 2014
External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiationKlaus Müller, Guido Henke, Inge Compter, et al.
Frontiers in Oncology|December 30, 2021
A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized TrialsMarco Skardelly, Marlene Kaltenstadler, Felix Behling, et al.
Neuro-Oncology Advances|April 29, 2024
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survivalDaniel Feucht, Patrick Haas, Marco Skardelly, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective EvaluationVlatko Potkrajcic, Cihan Gani, Stefan Georg Fischer, et al.
Frontiers in Oncology|March 7, 2022
Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression SurvivalFelix Behling, Julia Rang, Elena Dangel, et al.
Radiation Oncology (London, England)|March 17, 2010
Decreased 3D observer variation with matched CT-MRI, for target delineation in Nasopharynx cancerCoen R N Rasch, Roel J H M Steenbakkers, Isabelle Fitton, et al.
Cancers|April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
The Oncologist|April 1, 2017
Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed GlioblastomaMarco Skardelly, Elena Dangel, Julia Gohde, et al.
Clinical and Translational Radiation Oncology|June 23, 2021
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG surveyEnrica Seravalli, Petra S Kroon, John M Buatti, et al.
Clinical and Translational Radiation Oncology|December 20, 2023
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)Raphael Bodensohn, Daniel F Fleischmann, Sebastian H Maier, et al.
Pageof 12